Quality requirements for nanomedicines: which role for the European Pharmacopoeia? 7-8 June 2022, Strasbourg, France Working language: English Analytical challenges and current standardisation activities for nanomedicines by Fanny Caputo, LNE, France Regulatory challenges for nanomedicines by Jon de Vlieger, Lygature, the Netherlands Liposomal formulations and nanosimilars Scott McNeil, University of Basel, Switzerland The challenge of manufacturing complex nanomedicines: learnings from two decades of physicochemical iron carbohydrate characterisation Beat Flühmann, Vifor Pharma, Switzerland